95 MAGE-A1 protein expression pattern in > 5,000 tumor and healthy tissue samples: Validation of MAGE-A1 as an ideal target for TCR-based cell therapy

• Ronald Simon,
• Thomas Blankenstein,
• Jennifer Oduro,
• Natalia Gorbokon,
• Christoph Fraune,
• Julia Bluhm,
• Vivian Scheuplein,
• Elisa Kieback,
• Matthias Obenaus,
• Eugen Leo

Affiliations

Ronald Simon

2University Hospital Hamburg-Eppendorf, Hamburg, Germany

Thomas Blankenstein

1st Department of Obstetrics and Gynaecology, Ludwig-Maximilians-University Munich; and

Jennifer Oduro

1T-knife Therapeutics Inc., Berlin, Germany

Natalia Gorbokon

2University Hospital Hamburg-Eppendorf, Hamburg, Germany

Christoph Fraune

2University Hospital Hamburg-Eppendorf, Hamburg, Germany

Julia Bluhm

1T-knife Therapeutics Inc., Berlin, Germany

Vivian Scheuplein

1T-knife Therapeutics Inc., Berlin, Germany

Elisa Kieback

1T-knife Therapeutics Inc., Berlin, Germany

Matthias Obenaus

3Charite University Hospital, Berlin, Germany

Eugen Leo

1T-knife Therapeutics Inc., Berlin, Germany